The production value of Basic Pharmaceutical Products and Pharmaceutical Preparations in the Netherlands saw moderate fluctuations between 2013 and 2023, ending 2023 at approximately 6.5 billion euros. The year-on-year growth showed significant variation, from a substantial drop of 28.31% in 2013 to a peak increase of 18.67% in 2015. The most recent years displayed relatively steady growth, with a minor increase of 1.49% in 2023. The five-year Compound Annual Growth Rate (CAGR) averaged at 3.49%. Looking forward to 2024 and beyond, forecasts indicate a steady but slow growth, with a projected CAGR of 1.09% over the next five years, resulting in a production value of about 6.97 billion euros by 2028.
Future trends to watch for:
- Ongoing advancements in biotechnology and personalized medicine.
- Potential impacts of regulatory changes within the European Union.
- Developments in generic drugs and biosimilars market.
- The influence of global supply chain dynamics on production efficiency.
- Increased focus on sustainable practices within pharmaceutical manufacturing.
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
